LABD ETF Report: Ratings, Analysis, Quotes, Holdings

Popular LABD Comparisons: LABD vs BIS, LABD vs SQQQ, LABD vs SH, LABD vs SDS, LABD vs PSQ

Find more ETFs with our ETF Screener and Database

*Unless otherwise stated, data provided by FactSet.

LABD Fund Description

LABD provides daily 3 times inverse exposure to the S&P Biotechnology Select Industry Index.

LABD Factset Analytics Insight

LABD is a daily leveraged inverse (-3x) bet on an equal-weighted index of US biotech stocks. The vast majority of the fund's exposure is to biotechnology and medical research but also captures significant exposure to pharmaceuticals as well. As a leveraged product, the fund is not a buy-and-hold investment. It gets its leverage exposure through a through a portfolio of swaps that gets rebalanced at the end of each trading day. Because of that, the fund's return for periods longer than a day becomes path-dependent and is likely to be different from -3x the return of the index for the same period. This makes LABD suitable primarily for short-term traders. Over time, compounding effects can lead to profound differences in expected returns relative to the index.

PERFORMANCE [as of 07/23/21] 1 MONTH 3 MONTHS YTD 1 YEAR 3 YEARS 5 YEARS 10 YEARS

LABD 10.40% 3.56% -11.40% -59.89% -62.69% -66.43% --

LABD (NAV) 15.68% 6.35% -8.48% -63.15% -62.45% -66.19% --

S&P Biotechnology Select Industry Index -5.70% -5.63% -10.03% 10.40% 8.40% 16.59% 17.73%

N/A -- -- -- -- -- -- --

All returns over 1 year are annualized. All returns are total returns unless otherwise stated.

LABD Summary Data

Direxion

05/28/15

Open-Ended Fund

1.06%

$45.30M

0.10%

BIS

Fund Home Page

LABD Portfolio Data

5.48%

N/A

LABD Index Data

S&P Biotechnology Select Industry Index

Equal

Market Cap

N/A

LABD Fund Structure

Yes

-- / --

N/A

Medium

-3

Leverage Reset Frequency Daily

LABD Tax Exposures

20.00% / 39.60%

LABD Factset Analytics Block Liquidity

As of 07/26/21

This measurement shows how easy it is to trade a $1 million USD block of LABD. LABD is rated a N/A out of 5.

LABD Tradability

2,540,877

$54.01M

2,380,923

$48.79M

0.10%

$0.02

-0.06%

1,892.70% / -0.92%

None

97.00%

50,000

47.62

0.00%

25,446

$23.11

N/A

The data and information contained herein is not intended to be investment or tax advice. A reference to a particular investment or security, a credit rating, or any observation concerning a security or investment provided in the ETF.com Service is not a recommendation to buy, sell, or hold such investment or security or to make any other investment decisions. You should not use such information for purposes of any actual transaction without consulting an investment or tax professional.

ETF.com DOES NOT TAKE RESPONSIBILITY FOR YOUR INVESTMENT OR OTHER ACTIONS NOR SHALL ETF.com HAVE ANY LIABILITY, CONTINGENT OR OTHERWISE, FOR THE ACCURACY, COMPLETENESS, TIMELINESS, OR CORRECT SEQUENCING OF ANY INFORMATION PROVIDED BY ETF.com OR FOR ANY DECISION MADE OR ACTION TAKEN BY YOU IN RELIANCE UPON SUCH INFORMATION OR ETF.com.

[ETF.com DOES NOT PROVIDE ANY RESEARCH OPINIONS.] ETF.com MAKES NO REPRESENTATIONS ABOUT THE SUITABILITY OF THE INFORMATION, PRODUCTS OR SERVICES CONTAINED HEREIN. PAST PERFORMANCE IS NOT INDICATIVE OF FUTURE RESULTS.

Data provider:
Terms of Use

LABD